Acid Extrusion Via Blood-brain Barrier Causes Brain Alkalosis and Seizures After Neonatal Asphyxia
Overview
Affiliations
Birth asphyxia is often associated with a high seizure burden that is predictive of poor neurodevelopmental outcome. The mechanisms underlying birth asphyxia seizures are unknown. Using an animal model of birth asphyxia based on 6-day-old rat pups, we have recently shown that the seizure burden is linked to an increase in brain extracellular pH that consists of the recovery from the asphyxia-induced acidosis, and of a subsequent plateau level well above normal extracellular pH. In the present study, two-photon imaging of intracellular pH in neocortical neurons in vivo showed that pH changes also underwent a biphasic acid-alkaline response, resulting in an alkaline plateau level. The mean alkaline overshoot was strongly suppressed by a graded restoration of normocapnia after asphyxia. The parallel post-asphyxia increase in extra- and intracellular pH levels indicated a net loss of acid equivalents from brain tissue that was not attributable to a disruption of the blood-brain barrier, as demonstrated by a lack of increased sodium fluorescein extravasation into the brain, and by the electrophysiological characteristics of the blood-brain barrier. Indeed, electrode recordings of pH in the brain and trunk demonstrated a net efflux of acid equivalents from the brain across the blood-brain barrier, which was abolished by the Na/H exchange inhibitor, N-methyl-isobutyl amiloride. Pharmacological inhibition of Na/H exchange also suppressed the seizure activity associated with the brain-specific alkalosis. Our findings show that the post-asphyxia seizures are attributable to an enhanced Na/H exchange-dependent net extrusion of acid equivalents across the blood-brain barrier and to consequent brain alkalosis. These results suggest targeting of blood-brain barrier-mediated pH regulation as a novel approach in the prevention and therapy of neonatal seizures.
Ionescu M, Maria Catrina A, Dogaru I, Catalina Barbalata D, Ciotei C, Haidoiu C Reprod Fertil. 2024; 5(4).
PMID: 39374132 PMC: 11558923. DOI: 10.1530/RAF-24-0050.
Isac S, Pavel B, Dobre M, Milanesi E, Matache I, Paun R Life (Basel). 2022; 12(10).
PMID: 36295002 PMC: 9605013. DOI: 10.3390/life12101568.
Acetazolamide: Old drug, new evidence?.
Shukralla A, Dolan E, Delanty N Epilepsia Open. 2022; 7(3):378-392.
PMID: 35673961 PMC: 9436286. DOI: 10.1002/epi4.12619.
Early brain activity: Translations between bedside and laboratory.
Luhmann H, Kanold P, Molnar Z, Vanhatalo S Prog Neurobiol. 2022; 213:102268.
PMID: 35364141 PMC: 9923767. DOI: 10.1016/j.pneurobio.2022.102268.
Choudhary A, Mu C, Barrett K, Charkhand B, Williams-Dyjur C, Marks W Brain Commun. 2021; 3(4):fcab189.
PMID: 34734183 PMC: 8557655. DOI: 10.1093/braincomms/fcab189.